NCT03454594
- Conditions
- Arterial Occlusive Diseases, Arteriosclerosis, Cardiovascular Diseases, +13 more
- Locations
-
- Cairo Giza, Dokki, Egypt
Clinical trial condition
Hyperlipidemias
Explore clinical trials studying Hyperlipidemias. Study availability and eligibility vary by location and protocol.
1,231 public trials
93 recruiting studies
Hyperlipidemias trial results
NCT02584504
- Conditions
- Dyslipidemias, Hypercholesterolemia, Hyperlipidemias, +3 more
- Locations
-
- Investigational Site Number 392028 Ageo-Shi, Japan
- Investigational Site Number 392007 Chūōku, Japan
- Investigational Site Number 392029 Chūōku, Japan
- Investigational Site Number 392014 Fukui-shi, Japan
NCT01243151
- Conditions
- Dyslipidemia, Dyslipidemias, Hypercholesterolemia, +4 more
- Locations
-
- California Clinical Trials Medical Group Culver City, California, United States
- Glendale Adventist Medical Center Glendale, California, United States
- SeaView Research, Inc. Miami, Florida, United States
- SeaView Research, Inc. Miami, Florida, United States
NCT00687271
- Conditions
- Dyslipidemias, Hypercholesterolemia, Hyperlipidemias, +3 more
- Locations
-
Not specified
Completed
Digital Ankle Brachial Index (ABI) as a Screening Tool in Detecting Peripheral Arterial Disease
NCT03161327
- Conditions
- Amputation, Arterial Occlusive Diseases, Arteriosclerosis, +19 more
- Locations
-
- Saint Louis University St Louis, Missouri, United States
NCT01720537
- Conditions
- Dyslipidemias, Hypercholesterolemia, Hyperlipidemias, +3 more
- Locations
-
- Pfizer Investigational Site New Haven, Connecticut, United States
- Pfizer Investigational Site Miami, Florida, United States
- Pfizer Investigational Site South Miami, Florida, United States
- Pfizer Investigational Site Overland Park, Kansas, United States
NCT01212900
- Conditions
- Arterial Occlusive Diseases, Arteriosclerosis, Atherosclerosis, +8 more
- Locations
-
- National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States
NCT01588496
- Conditions
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Genetic Diseases, Inborn, +10 more
- Locations
-
- Research Site New York, United States
- Research Site Cincinnati, Ohio, United States
- Research Site Brussels, Belgium
- Research Site La Louvière, Belgium
NCT01849497
- Conditions
- Dyslipidemias, Hypercholesterolemia, Hyperlipidemias, +5 more
- Locations
-
- Research Site Encino, California, United States
- Research Site Thousand Oaks, California, United States
- Research Site Ventura, California, United States
- Research Site Westlake Village, California, United States
Completed
A Study to Evaluate Tolerability and Efficacy of Evolocumab (AMG 145) in Japanese Subjects
NCT01652703
- Conditions
- Dyslipidemias, Hypercholesterolemia, Hypercholesterolemia and High Risk for Cardiovascular Events, +4 more
- Locations
-
- Research Site Nagoya, Aichi-ken, Japan
- Research Site Nagoya, Aichi-ken, Japan
- Research Site Nagoya, Aichi-ken, Japan
- Research Site Fukui-shi, Fukui, Japan